drugset / Trial / NCT05909293
Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission
Recruiting
100 enrolled
The First Affiliated Hospital with Nanjing Medical University
Huai'an First People's Hospital · collabYancheng First People's Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
This clinical study evaluates the efficacy and safety of maintenance therapy with BCL-2 inhibitors in elderly patients with acute myeloid leukemia (AML) in first complete remission. This study involves the following content: BCL-2 inhibitors.
Timeline
- Start
- 2023-04-12
- Primary completion
- 2025-05-30
- Completion
- 2028-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Venetoclax | Small molecule | 400 mg | Oral |